Survey of the Pancreatic Cancer Drug Market With Celgene's Abraxane in Focus

Published December 2, 2012

Survey Of The Pancreatic Cancer Drug Market With Celgene's Abraxane In Focus

Filed under: drug treatment news articles

Earlier this year, in August, the FDA approved Xtandi (enzalutamide)- to be marketed by Medivation (MDVN) for the treatment of metastatic castration-resistant prostate cancer. Per a FDA news release from September 27, 2012, Stivarga, a multi-kinase …
Read more on Seeking Alpha

Rockwell Medical Readying 2 Drugs For Dialysis

Filed under: drug treatment news articles

I wrote this article myself, and it expresses my own opinions. I am not … With a fleet of more than 50 tractor trailers, the company sends boxes of dialysate powder to dialysis clinics across the country where they get mixed with water into a liquid …
Read more on Seeking Alpha

Transformation Underway At Cipher

Filed under: drug treatment news articles

I wrote this article myself, and it expresses my own opinions. I am not receiving … PK) announced it had received U.S. FDA approval of Absorica, the company's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of …
Read more on Seeking Alpha